LEN Lennar | $156.61 +0.0% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral | $130.00 -> $144.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/18/2024 |
TNGX Tango Therapeutics | $8.39 -7.1% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $18.00 | Low | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 3/18/2024 |
LOGI Logitech International | $88.16 -6.9% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral | $92.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 3/18/2024 |
TSLA Tesla | $173.80 +6.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $315.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/13/2024 |
MLTX MoonLake Immunotherapeutics | $48.56 +2.8% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $20.48 +6.0% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $32.00 | Low | View details for Wedbush rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
|
PRPL Purple Innovation | $1.51 -3.2% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1.25 -> $2.25 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 3/13/2024 |
BIRD Allbirds | $0.70 -4.1% | 3/13/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $1.00 -> $0.90 | Low | View details for Wedbush rating of Allbirds (NASDAQ:BIRD) on 3/13/2024 |
TPX Tempur Sealy International | $52.59 -0.8% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $60.00 -> $66.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 3/13/2024 |
INFY Infosys | $19.17 -0.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of Infosys (NYSE:INFY) on 3/13/2024 |
DRI Darden Restaurants | $172.87 +0.5% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/15/2024 |
PGY Pagaya Technologies | $9.87 -8.4% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $18.00 -> $11.50 | Low | View details for Wedbush rating of Pagaya Technologies (NASDAQ:PGY) on 3/15/2024 |
GERN Geron | $3.18 -5.6% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Geron (NASDAQ:GERN) on 3/15/2024 |
DECK Deckers Outdoor | $909.50 0.0% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $895.00 -> $1,000.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 3/15/2024 |
RMBL RumbleON | $5.71 +8.1% | 3/15/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $7.50 -> $7.00 | Low | View details for Wedbush rating of RumbleON (NASDAQ:RMBL) on 3/15/2024 |
DKS DICK'S Sporting Goods | $213.04 +0.7% | 3/15/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $160.00 -> $210.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 3/15/2024 |
SKLZ Skillz | $6.11 -2.9% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of Skillz (NYSE:SKLZ) on 3/15/2024 |
GETY Getty Images | $4.73 -8.5% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $7.70 | Low | View details for Wedbush rating of Getty Images (NYSE:GETY) on 3/15/2024 |
STKS ONE Group Hospitality | $4.20 +5.8% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $6.00 -> $5.00 | Low | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/15/2024 |
NHI National Health Investors | $60.57 +0.8% | 3/18/2024 | Target Raised by | Wedbush | Analyst R. Anderson | Outperform -> Outperform | $64.00 -> $66.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 3/18/2024 |
TSVT 2seventy bio | $4.19 +4.5% | 3/18/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 3/18/2024 |
FENC Fennec Pharmaceuticals | $11.07 +11.4% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $16.00 | Low | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/18/2024 |
HEAR Turtle Beach | $16.75 +8.7% | 3/14/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $19.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/14/2024 |
S SentinelOne | $23.18 +4.9% | 3/14/2024 | Target Raised by | Wedbush | - | Overweight -> Overweight | $28.00 -> $32.00 | Low | View details for Wedbush rating of SentinelOne (NYSE:S) on 3/14/2024 |
JACK Jack in the Box | $71.91 -2.0% | 3/14/2024 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $79.00 -> $88.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 3/14/2024 |
CLSD Clearside Biomedical | $1.56 -8.8% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of Clearside Biomedical (NASDAQ:CLSD) on 3/13/2024 |
BDTX Black Diamond Therapeutics | $4.70 -1.9% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $10.00 | Low | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/13/2024 |
GEO The GEO Group | $12.87 -2.1% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/13/2024 |
NCMI National CineMedia | $4.22 -0.5% | 3/12/2024 | Reiterated by | Wedbush | - | Neutral | $4.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/12/2024 |
INZY Inozyme Pharma | $6.00 +1.9% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 3/12/2024 |
IKNA Ikena Oncology | $1.50 -4.5% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 3/12/2024 |
MU Micron Technology | $93.78 +0.6% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 -> $103.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/12/2024 |
ANAB AnaptysBio | $23.17 -1.2% | 3/12/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Neutral -> Outperform | $20.00 -> $34.00 | Low | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 3/12/2024 |
JANX Janux Therapeutics | $38.81 -1.6% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $53.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 3/11/2024 |
SPRY ARS Pharmaceuticals | $9.12 -0.4% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | Low | View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/11/2024 |
PLTR Palantir Technologies | $24.00 +2.2% | 3/8/2024 | Reiterated by | Wedbush | - | Outperform | $30.00 -> $35.00 | Low | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 3/8/2024 |
PEPG PepGen | $13.65 -11.6% | 3/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $21.00 -> $20.00 | Low | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 3/7/2024 |
ELEV Elevation Oncology | $4.36 -0.7% | 3/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.00 -> $8.00 | Low | View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2024 |
GBIO Generation Bio | $2.96 -4.2% | 3/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 3/7/2024 |
WSM Williams-Sonoma | $285.42 +0.6% | 3/7/2024 | Target Raised by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $230.00 -> $280.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/7/2024 |
AI Cracks Open Largest Untapped Energy Reserve on Earth (Ad) This orb represents the largest untapped energy source in the world…
And although this energy resource is unknown by 99% of the public…
It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit |
NYCB New York Community Bancorp | $3.62 -7.2% | 3/7/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.50 -> $3.00 | N/A | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/7/2024 |
SOFI SoFi Technologies | $7.08 +0.7% | 3/6/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.00 | Low | View details for Wedbush rating of SoFi Technologies (NASDAQ:SOFI) on 3/6/2024 |
OCS Oculis | $11.85 +4.2% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $29.00 | Low | View details for Wedbush rating of Oculis (NASDAQ:OCS) on 3/6/2024 |
GOSS Gossamer Bio | $1.38 -5.5% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 3/6/2024 |
HEAR Turtle Beach | $16.75 +8.7% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/6/2024 |
TCRX TScan Therapeutics | $6.83 -4.1% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 -> $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 3/6/2024 |
ITOS iTeos Therapeutics | $10.26 -5.1% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 -> $18.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/6/2024 |
APGE Apogee Therapeutics | $65.44 -4.2% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform | $40.00 -> $87.00 | Low | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 3/5/2024 |
ATXS Astria Therapeutics | $15.61 +1.0% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/5/2024 |
LEN Lennar | $156.61 +0.0% | 3/5/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/5/2024 |
TDUP ThredUp | $1.90 -0.5% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $4.00 | Low | View details for Wedbush rating of ThredUp (NASDAQ:TDUP) on 3/5/2024 |
SFIX Stitch Fix | $2.27 +0.9% | 3/5/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $4.00 -> $3.00 | Low | View details for Wedbush rating of Stitch Fix (NASDAQ:SFIX) on 3/5/2024 |
CCS Century Communities | $87.38 -0.7% | 3/5/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $92.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 3/5/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 3/5/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $278.00 -> $350.00 | Low | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2024 |
MELI MercadoLibre | $1,509.05 +0.6% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $2,000.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 3/5/2024 |
SE SEA | $57.85 -0.5% | 3/5/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $45.00 -> $72.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 3/5/2024 |
CELH Celsius | $89.54 -3.6% | 3/4/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $90.00 | Low | View details for Wedbush rating of Celsius (NASDAQ:CELH) on 3/4/2024 |
FUBO fuboTV | $1.55 +2.0% | 3/4/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 3/4/2024 |
IMAX IMAX | $15.71 -4.8% | 3/4/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 3/4/2024 |
ZS Zscaler | $195.94 +1.0% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $250.00 -> $260.00 | Low | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 3/1/2024 |
SOUN SoundHound AI | $8.24 -7.5% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.00 -> $9.00 | Low | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 3/1/2024 |
NYCB New York Community Bancorp | $3.62 -7.2% | 3/1/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $5.00 -> $3.50 | Low | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/1/2024 |
VRNA Verona Pharma | $15.53 -0.8% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 | Low | View details for Wedbush rating of Verona Pharma (NASDAQ:VRNA) on 3/1/2024 |
MLTX MoonLake Immunotherapeutics | $48.56 +2.8% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/1/2024 |
XENE Xenon Pharmaceuticals | $42.89 -2.4% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $46.00 -> $51.00 | Low | View details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 3/1/2024 |
ORIC ORIC Pharmaceuticals | $14.68 -2.8% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $12.00 -> $20.00 | Low | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/1/2024 |
NUVB Nuvation Bio | $2.26 -0.9% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 3/1/2024 |
GRBK Green Brick Partners | $54.91 +0.5% | 3/1/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $45.00 | Low | View details for Wedbush rating of Green Brick Partners (NASDAQ:GRBK) on 3/1/2024 |
BBY Best Buy | $77.13 -1.1% | 3/1/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $75.00 -> $85.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 3/1/2024 |
NTAP NetApp | $101.80 -0.5% | 3/1/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $85.00 -> $100.00 | Low | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 3/1/2024 |
LSEA Landsea Homes | $12.00 -3.4% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $16.00 | Low | View details for Wedbush rating of Landsea Homes (NASDAQ:LSEA) on 3/1/2024 |
PZZA Papa John's International | $71.75 +3.1% | 3/1/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $87.00 | Low | View details for Wedbush rating of Papa John’s International (NASDAQ:PZZA) on 3/1/2024 |
PSTG Pure Storage | $50.60 +1.3% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $50.00 | Low | View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 2/29/2024 |
SRPT Sarepta Therapeutics | $123.97 +0.7% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/29/2024 |
KROS Keros Therapeutics | $63.86 -5.2% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $86.00 | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 2/29/2024 |
SBRA Sabra Health Care REIT | $14.18 +0.4% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $17.00 | Low | View details for Wedbush rating of Sabra Health Care REIT (NASDAQ:SBRA) on 2/29/2024 |
CRM Salesforce | $300.51 +2.1% | 2/29/2024 | Target Raised by | Wedbush | - | Buy -> Buy | $280.00 -> $325.00 | Low | View details for Wedbush rating of Salesforce (NYSE:CRM) on 2/29/2024 |
AI C3.ai | $29.05 +0.4% | 2/29/2024 | Target Lowered by | Wedbush | - | Overweight -> Overweight | $42.00 -> $35.00 | Low | View details for Wedbush rating of C3.ai (NYSE:AI) on 2/29/2024 |
DIN Dine Brands Global | $46.92 -1.2% | 2/29/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $46.00 -> $48.00 | Low | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 2/29/2024 |
MRSN Mersana Therapeutics | $4.86 -3.6% | 2/29/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Neutral -> Outperform | $2.00 -> $7.00 | Low | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
YOU Clear Secure | $19.32 +0.2% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral | $23.00 | Low | View details for Wedbush rating of Clear Secure (NYSE:YOU) on 2/28/2024 |
GTHX G1 Therapeutics | $3.21 +3.2% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $4.00 -> $5.00 | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 2/28/2024 |
KNSA Kiniksa Pharmaceuticals | $19.58 -2.1% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $28.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 2/28/2024 |
MNKD MannKind | $4.62 +3.4% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 | Low | View details for Wedbush rating of MannKind (NASDAQ:MNKD) on 2/28/2024 |
RDFN Redfin | $5.59 -7.0% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral | $8.00 | Low | View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 2/28/2024 |
AAPL Apple | $173.72 +0.6% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 2/28/2024 |
SNOW Snowflake | $156.31 -0.4% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $144.00 -> $210.00 | Low | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 2/28/2024 |
APLS Apellis Pharmaceuticals | $56.26 -0.8% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $60.00 -> $67.00 | Low | View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 2/28/2024 |
DNLI Denali Therapeutics | $20.09 -0.2% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $31.00 | Low | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 2/28/2024 |
ARVN Arvinas | $42.60 -5.0% | 2/28/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Outperform -> Outperform | $33.00 -> $59.00 | Low | View details for Wedbush rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
Central Bank Gold Heist In Progress (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
XNCR Xencor | $22.25 -3.6% | 2/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $36.00 -> $34.00 | Low | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 2/28/2024 |
ZNTL Zentalis Pharmaceuticals | $13.86 -3.2% | 2/28/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Neutral -> Neutral | $12.00 -> $15.00 | Low | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 2/28/2024 |
RGNX REGENXBIO | $22.33 +0.6% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 | Low | View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 2/28/2024 |
VRDN Viridian Therapeutics | $17.34 +1.5% | 2/28/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $39.00 -> $40.00 | Low | View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 2/28/2024 |
KURA Kura Oncology | $21.04 -5.8% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 2/28/2024 |
RVLV Revolve Group | $20.85 -0.7% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $12.00 -> $17.00 | Low | View details for Wedbush rating of Revolve Group (NYSE:RVLV) on 2/28/2024 |
LOW Lowe's Companies | $243.48 -0.5% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $215.00 -> $250.00 | Low | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 2/28/2024 |
AZO AutoZone | $3,106.87 -0.6% | 2/28/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $2,950.00 -> $3,400.00 | Low | View details for Wedbush rating of AutoZone (NYSE:AZO) on 2/28/2024 |
NUVL Nuvalent | $78.11 -3.3% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform | $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 2/27/2024 |
BEAM Beam Therapeutics | $34.07 -3.8% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform | $48.00 -> $57.00 | Low | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 2/27/2024 |
PLTK Playtika | $7.05 -1.4% | 2/27/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $14.75 -> $11.50 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 2/27/2024 |
ZM Zoom Video Communications | $66.23 +0.4% | 2/27/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $80.00 | Low | View details for Wedbush rating of Zoom Video Communications (NASDAQ:ZM) on 2/27/2024 |
U Unity Software | $26.07 -0.1% | 2/27/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $50.00 -> $33.50 | Low | View details for Wedbush rating of Unity Software (NYSE:U) on 2/27/2024 |
CAVA CAVA Group | $62.07 -3.3% | 2/27/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 2/27/2024 |
FATE Fate Therapeutics | $7.04 -6.0% | 2/27/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $3.00 -> $7.00 | Low | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024 |
RVMD Revolution Medicines | $30.94 -2.8% | 2/27/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Outperform -> Outperform | $41.00 -> $42.00 | Low | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 2/27/2024 |
JANX Janux Therapeutics | $38.81 -1.6% | 2/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $24.00 -> $53.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 2/27/2024 |
CELH Celsius | $89.54 -3.6% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $75.00 -> $90.00 | Low | View details for Wedbush rating of Celsius (NASDAQ:CELH) on 2/27/2024 |
DPZ Domino's Pizza | $442.86 +0.4% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform | $445.00 -> $520.00 | Low | View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 2/26/2024 |
TCRX TScan Therapeutics | $6.83 -4.1% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 2/26/2024 |
RITM Rithm Capital | $10.87 -0.5% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 2/26/2024 |
SWTX SpringWorks Therapeutics | $48.43 -3.7% | 2/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $60.00 -> $70.00 | Low | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/26/2024 |
KDP Keurig Dr Pepper | $29.51 +2.2% | 2/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $37.00 -> $35.00 | Low | View details for Wedbush rating of Keurig Dr Pepper (NASDAQ:KDP) on 2/26/2024 |
NHI National Health Investors | $60.57 +0.8% | 2/26/2024 | Upgraded by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $57.00 -> $64.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 2/26/2024 |
AMC AMC Entertainment | $4.40 -1.1% | 2/23/2024 | Reiterated by | Wedbush | Analyst A. Reese | Neutral -> Neutral | $6.00 | Low | View details for Wedbush rating of AMC Entertainment (NYSE:AMC) on 2/23/2024 |
SNBR Sleep Number | $13.25 -2.1% | 2/23/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $12.00 -> $13.50 | Low | View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 2/23/2024 |
W Wayfair | $60.23 -1.2% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/23/2024 |
FND Floor & Decor | $118.76 -1.6% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $115.00 -> $125.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/23/2024 |
AXTI AXT | $4.85 -0.4% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 2/23/2024 |
PRGS Progress Software | $52.82 +0.5% | 2/23/2024 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $65.00 -> $67.00 | Low | View details for Wedbush rating of Progress Software (NASDAQ:PRGS) on 2/23/2024 |
BKNG Booking | $3,450.93 +1.1% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $3,850.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 2/23/2024 |
MELI MercadoLibre | $1,509.05 +0.6% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1,800.00 -> $2,000.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 2/23/2024 |
IMAX IMAX | $15.71 -4.8% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 2/23/2024 |
ZD Ziff Davis | $62.05 -0.9% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $78.00 | Low | View details for Wedbush rating of Ziff Davis (NASDAQ:ZD) on 2/23/2024 |
NICE NICE | $238.84 +0.4% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $230.00 -> $270.00 | Low | View details for Wedbush rating of NICE (NASDAQ:NICE) on 2/23/2024 |
COGT Cogent Biosciences | $6.74 -4.4% | 2/23/2024 | Target Raised by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $5.00 -> $10.00 | Low | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 2/23/2024 |
CRI Carter's | $84.33 -2.0% | 2/23/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $67.00 -> $78.00 | Low | View details for Wedbush rating of Carter’s (NYSE:CRI) on 2/23/2024 |
CHUY Chuy's | $34.11 +1.0% | 2/23/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $41.00 -> $38.00 | Low | View details for Wedbush rating of Chuy’s (NASDAQ:CHUY) on 2/23/2024 |
RKT Rocket Companies | $12.25 -0.5% | 2/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $13.00 | Low | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 2/23/2024 |
ARDX Ardelyx | $7.84 -3.2% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 2/23/2024 |
ALIT Alight | $8.65 -0.2% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 2/22/2024 |
EPAM EPAM Systems | $292.70 -2.1% | 2/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $320.00 -> $340.00 | Low | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 2/22/2024 |
UTHR United Therapeutics | $233.97 -0.8% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $308.00 | Low | View details for Wedbush rating of United Therapeutics (NASDAQ:UTHR) on 2/22/2024 |
RCUS Arcus Biosciences | $17.23 -9.2% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $30.00 | Low | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 2/22/2024 |
UFPI UFP Industries | $114.23 -1.2% | 2/22/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $102.00 | Low | View details for Wedbush rating of UFP Industries (NASDAQ:UFPI) on 2/22/2024 |
NVDA NVIDIA | $884.55 +0.7% | 2/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $800.00 -> $850.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
ETSY Etsy | $66.07 -0.3% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $85.00 -> $80.00 | Low | View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 2/22/2024 |
MTTR Matterport | $1.83 +3.4% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $5.00 -> $4.00 | Low | View details for Wedbush rating of Matterport (NASDAQ:MTTR) on 2/22/2024 |
WING Wingstop | $339.55 -2.3% | 2/22/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $330.00 -> $340.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/22/2024 |
BROS Dutch Bros | $34.14 +0.6% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 2/22/2024 |
Make This $3 Trade the Instant the Opening Bell Rings (Ad) Since the birth of Wall Street, one simple rule has remained the same....
Buy stocks that are cheap....When they’re on sale….
And when nobody else is looking… See Why This $3.00 Stock Could Hit $15.00 |
JACK Jack in the Box | $71.91 -2.0% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $83.00 -> $79.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024 |
CAKE Cheesecake Factory | $35.65 -0.3% | 2/22/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $40.00 | Low | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024 |
SPRY ARS Pharmaceuticals | $9.12 -0.4% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | Low | View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 2/21/2024 |
TOL Toll Brothers | $119.61 -0.6% | 2/21/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $87.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 2/21/2024 |
HD Home Depot | $371.89 -0.4% | 2/21/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $380.00 | Low | View details for Wedbush rating of Home Depot (NYSE:HD) on 2/21/2024 |
FUBO fuboTV | $1.55 +2.0% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 2/21/2024 |
PLTK Playtika | $7.05 -1.4% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.75 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 2/21/2024 |
BYON Beyond | $34.02 +0.4% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 -> $35.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/21/2024 |
LGIH LGI Homes | $106.69 -0.3% | 2/21/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $97.00 -> $88.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 2/21/2024 |
AZO AutoZone | $3,106.87 -0.6% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $2,950.00 | Low | View details for Wedbush rating of AutoZone (NYSE:AZO) on 2/20/2024 |
CVNA Carvana | $80.77 +1.5% | 2/20/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $40.00 -> $50.00 | Low | View details for Wedbush rating of Carvana (NYSE:CVNA) on 2/20/2024 |
SRPT Sarepta Therapeutics | $123.97 +0.7% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/20/2024 |
SQ Block | $80.88 +0.9% | 2/20/2024 | Reiterated by | Wedbush | Analyst M. Katri | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of Block (NYSE:SQ) on 2/20/2024 |
AIP Arteris | $6.32 -2.5% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Arteris (NASDAQ:AIP) on 2/20/2024 |
ABR Arbor Realty Trust | $12.78 -1.4% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 2/20/2024 |
TPH Tri Pointe Homes | $34.19 -0.1% | 2/20/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $32.00 | Low | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 2/20/2024 |
DOOR Masonite International | $130.74 +0.0% | 2/20/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $133.00 | Low | View details for Wedbush rating of Masonite International (NYSE:DOOR) on 2/20/2024 |
HR Healthcare Realty Trust | $13.13 -0.3% | 2/20/2024 | Downgraded by | Wedbush | Analyst R. Anderson | Outperform -> Neutral | $19.00 -> $15.00 | Low | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 2/20/2024 |
HPP Hudson Pacific Properties | $6.44 +0.8% | 2/20/2024 | Downgraded by | Wedbush | Analyst R. Anderson | Outperform -> Neutral | $11.00 -> $7.50 | Low | View details for Wedbush rating of Hudson Pacific Properties (NYSE:HPP) on 2/20/2024 |
COIN Coinbase Global | $239.62 -1.1% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $180.00 -> $200.00 | Low | View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 2/16/2024 |
DASH DoorDash | $129.58 -0.7% | 2/16/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $92.00 -> $115.00 | Low | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 2/16/2024 |
PANW Palo Alto Networks | $285.24 +1.1% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $350.00 -> $425.00 | Low | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 2/16/2024 |
INTC Intel | $42.71 +0.2% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of Intel (NASDAQ:INTC) on 2/16/2024 |
W Wayfair | $60.23 -1.2% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/16/2024 |
ROKU Roku | $63.37 -1.0% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/16/2024 |
RNG RingCentral | $35.49 +1.5% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of RingCentral (NYSE:RNG) on 2/16/2024 |
GLOB Globant | $207.02 -4.4% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Globant (NYSE:GLOB) on 2/16/2024 |
GPC Genuine Parts | $153.49 -0.1% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $140.00 | Low | View details for Wedbush rating of Genuine Parts (NYSE:GPC) on 2/16/2024 |
RARE Ultragenyx Pharmaceutical | $46.59 -1.6% | 2/16/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $47.00 -> $48.00 | Low | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/16/2024 |
TVTX Travere Therapeutics | $7.18 -4.1% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 2/16/2024 |
WD Walker & Dunlop | $89.06 -0.5% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $130.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 2/16/2024 |
NVDA NVIDIA | $884.55 +0.7% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $800.00 -> $850.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/16/2024 |
KMX CarMax | $79.83 -1.1% | 2/16/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 2/16/2024 |
FND Floor & Decor | $118.76 -1.6% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $85.00 -> $115.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/16/2024 |
BJRI BJ's Restaurants | $35.26 +0.5% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $40.00 | Low | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 2/16/2024 |
TXRH Texas Roadhouse | $152.00 -0.2% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $145.00 -> $160.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/16/2024 |
WEN Wendy's | $18.21 -0.7% | 2/16/2024 | Target Lowered by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $20.00 -> $19.00 | Low | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/16/2024 |
NTLA Intellia Therapeutics | $27.37 -3.3% | 2/15/2024 | Reiterated by | Wedbush | - | Neutral | $29.00 | Low | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/15/2024 |
GEO The GEO Group | $12.87 -2.1% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 2/15/2024 |
MGPI MGP Ingredients | $82.60 -1.2% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $135.00 | Low | View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 2/15/2024 |
APP AppLovin | $68.15 +8.0% | 2/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $58.50 -> $67.00 | Low | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 2/15/2024 |
PEGA Pegasystems | $63.12 +1.7% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $58.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 2/15/2024 |
TRIP Tripadvisor | $27.82 +1.8% | 2/15/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 | Low | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 2/15/2024 |
GLUE Monte Rosa Therapeutics | $6.70 +4.5% | 2/15/2024 | Initiated by | Wedbush | - | Outperform | $11.00 | Low | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 2/15/2024 |
CGEM Cullinan Oncology | $15.32 -3.8% | 2/15/2024 | Initiated by | Wedbush | - | Outperform | $30.00 | Low | View details for Wedbush rating of Cullinan Oncology (NASDAQ:CGEM) on 2/15/2024 |
WING Wingstop | $339.55 -2.3% | 2/14/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $280.00 -> $330.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/14/2024 |
SHAK Shake Shack | $104.79 +1.1% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $80.00 | Low | View details for Wedbush rating of Shake Shack (NYSE:SHAK) on 2/14/2024 |
BYON Beyond | $34.02 +0.4% | 2/14/2024 | Reiterated by | Wedbush | - | Outperform | $33.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/14/2024 |
LYFT Lyft | $17.95 +4.2% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral | $14.00 -> $15.00 | Low | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 2/14/2024 |
ABNB Airbnb | $161.86 +0.8% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral | $150.00 -> $160.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 2/14/2024 |
Did you make $29,000 two days with AI options trades? (Ad) What if it was possible to find options trades on autopilot…
Using A.I. to find the ones with the highest profit potential…
And nearly perfect win rates…
You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below: Click Here To Get Your Free Copy |
DENN Denny's | $8.80 -1.3% | 2/14/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $11.00 -> $10.50 | Low | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 2/14/2024 |
SHOP Shopify | $77.53 +0.5% | 2/13/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $68.00 | Low | View details for Wedbush rating of Shopify (NYSE:SHOP) on 2/13/2024 |
GTHX G1 Therapeutics | $3.21 +3.2% | 2/13/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 2/13/2024 |
CNK Cinemark | $18.29 -0.3% | 2/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 2/13/2024 |
YMAB Y-mAbs Therapeutics | $13.76 -6.4% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $12.00 -> $18.00 | Low | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 2/12/2024 |
CMRX Chimerix | $1.10 -4.3% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | Low | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 2/12/2024 |
NUVL Nuvalent | $78.11 -3.3% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $82.00 -> $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 2/12/2024 |
BIIB Biogen | $219.40 +0.0% | 2/12/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $239.00 -> $245.00 | Low | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 2/12/2024 |
COOP Mr. Cooper Group | $72.87 -2.4% | 2/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $80.00 -> $85.00 | Low | View details for Wedbush rating of Mr. Cooper Group (NASDAQ:COOP) on 2/12/2024 |
RGNX REGENXBIO | $22.33 +0.6% | 2/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 | Low | View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 2/12/2024 |
BLDR Builders FirstSource | $195.44 0.0% | 2/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $175.00 -> $225.00 | Low | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 2/12/2024 |
DBD Diebold Nixdorf | $34.98 +0.1% | 2/12/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Neutral -> Neutral | $25.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 2/12/2024 |
AAPL Apple | $173.72 +0.6% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 2/12/2024 |
CXW CoreCivic | $14.52 -2.2% | 2/9/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $17.00 -> $18.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 2/9/2024 |
AFRM Affirm | $34.21 +1.5% | 2/9/2024 | Reiterated by | Wedbush | - | Underperform -> Underperform | $20.00 | Low | View details for Wedbush rating of Affirm (NASDAQ:AFRM) on 2/9/2024 |
ROKU Roku | $63.37 -1.0% | 2/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/9/2024 |
TTWO Take-Two Interactive Software | $144.62 +0.5% | 2/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $190.00 | Low | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 2/9/2024 |
EXPE Expedia Group | $133.21 -0.2% | 2/9/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 2/9/2024 |
PINS Pinterest | $33.98 -0.6% | 2/9/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $35.00 -> $38.00 | Low | View details for Wedbush rating of Pinterest (NYSE:PINS) on 2/9/2024 |
PEP PepsiCo | $171.26 +4.0% | 2/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $195.00 | Low | View details for Wedbush rating of PepsiCo (NASDAQ:PEP) on 2/9/2024 |
ORLY O'Reilly Automotive | $1,113.83 +0.1% | 2/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $940.00 -> $1,100.00 | Low | View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/8/2024 |
SIMO Silicon Motion Technology | $73.85 +1.9% | 2/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 | Low | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 2/8/2024 |
RBLX Roblox | $36.20 -7.7% | 2/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $53.00 -> $56.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 2/8/2024 |
QLYS Qualys | $166.62 +0.2% | 2/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $230.00 -> $210.00 | Low | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 2/8/2024 |
PYPL PayPal | $64.23 +2.2% | 2/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 | Low | View details for Wedbush rating of PayPal (NASDAQ:PYPL) on 2/8/2024 |
ASND Ascendis Pharma A/S | $147.06 -1.1% | 2/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $207.00 -> $225.00 | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/8/2024 |
PCRX Pacira BioSciences | $29.29 -0.4% | 2/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $57.00 | Low | View details for Wedbush rating of Pacira BioSciences (NASDAQ:PCRX) on 2/8/2024 |
GPRO GoPro | $2.17 -2.3% | 2/8/2024 | Downgraded by | Wedbush | Analyst A. Reese | Outperform -> Neutral | $4.00 -> $2.00 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 2/8/2024 |
CMG Chipotle Mexican Grill | $2,773.53 +0.6% | 2/7/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $2,400.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 2/7/2024 |
TXRH Texas Roadhouse | $152.00 -0.2% | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $130.00 -> $145.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/7/2024 |
WEN Wendy's | $18.21 -0.7% | 2/7/2024 | Target Lowered by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $21.00 -> $20.00 | Low | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/7/2024 |
CRSR Corsair Gaming | $12.16 -0.5% | 2/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $21.00 | Low | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 2/7/2024 |
SHOO Steven Madden | $40.86 -1.8% | 2/7/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $36.00 -> $38.00 | Low | View details for Wedbush rating of Steven Madden (NASDAQ:SHOO) on 2/7/2024 |
RLYB Rallybio | $1.63 +0.6% | 2/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $14.00 -> $13.00 | Low | View details for Wedbush rating of Rallybio (NASDAQ:RLYB) on 2/7/2024 |
VFC V.F. | $14.39 -2.6% | 2/7/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $16.50 -> $15.50 | Low | View details for Wedbush rating of V.F. (NYSE:VFC) on 2/7/2024 |
CRNC Cerence | $14.41 -2.6% | 2/7/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $19.00 -> $21.00 | N/A | View details for Wedbush rating of Cerence (NASDAQ:CRNC) on 2/7/2024 |
CHKP Check Point Software Technologies | $166.48 +1.1% | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $170.00 -> $185.00 | Low | View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 2/7/2024 |
TENB Tenable | $46.94 +2.2% | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $50.00 -> $65.00 | Low | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 2/7/2024 |
FTNT Fortinet | $67.55 +1.2% | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $86.00 | Low | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 2/7/2024 |
SKY Skyline Champion | $79.85 -1.5% | 2/6/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $72.00 | Low | View details for Wedbush rating of Skyline Champion (NYSE:SKY) on 2/6/2024 |
LGIH LGI Homes | $106.69 -0.3% | 2/6/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $97.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 2/6/2024 |
RANI Rani Therapeutics | $3.34 +0.6% | 2/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $8.00 | Low | View details for Wedbush rating of Rani Therapeutics (NASDAQ:RANI) on 2/6/2024 |
PLTR Palantir Technologies | $24.00 +2.2% | 2/6/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $25.00 -> $30.00 | Low | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 2/6/2024 |
VRNS Varonis Systems | $49.15 +0.5% | 2/6/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $35.00 -> $65.00 | Low | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 2/6/2024 |
MCD McDonald's | $278.61 -0.2% | 2/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $330.00 | Low | View details for Wedbush rating of McDonald’s (NYSE:MCD) on 2/6/2024 |
ACET Adicet Bio | $1.95 -2.5% | 2/5/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 2/5/2024 |
BPMC Blueprint Medicines | $86.82 -4.1% | 2/5/2024 | Reiterated by | Wedbush | - | Outperform | $97.00 | Low | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 2/5/2024 |
GPRO GoPro | $2.17 -2.3% | 2/2/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 2/2/2024 |
META Meta Platforms | $496.98 +2.7% | 2/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $420.00 -> $520.00 | Low | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 2/2/2024 |
DECK Deckers Outdoor | $909.50 0.0% | 2/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $825.00 -> $895.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 2/2/2024 |
BZH Beazer Homes USA | $29.42 -0.6% | 2/2/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $32.00 -> $33.00 | Low | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 2/2/2024 |
SKX Skechers U.S.A. | $60.17 -1.2% | 2/2/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $75.00 -> $68.00 | Low | View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 2/2/2024 |
TSCO Tractor Supply | $255.72 -0.6% | 2/2/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $200.00 -> $235.00 | Low | View details for Wedbush rating of Tractor Supply (NASDAQ:TSCO) on 2/2/2024 |
AMZN Amazon.com | $174.48 +0.0% | 2/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $210.00 -> $220.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 2/2/2024 |
MTH Meritage Homes | $155.43 -1.2% | 2/1/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $170.00 | Low | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 2/1/2024 |
TCRX TScan Therapeutics | $6.83 -4.1% | 2/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $9.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 2/1/2024 |
NYCB New York Community Bancorp | $3.62 -7.2% | 2/1/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $6.00 | Low | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 2/1/2024 |
CCS Century Communities | $87.38 -0.7% | 2/1/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $81.00 -> $92.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 2/1/2024 |
RBLX Roblox | $36.20 -7.7% | 1/31/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $53.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 1/31/2024 |
PHM PulteGroup | $110.18 -0.6% | 1/31/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $85.00 | Low | View details for Wedbush rating of PulteGroup (NYSE:PHM) on 1/31/2024 |